- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02288598
Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering
January 30, 2017 updated by: University of Oxford
This study aims to test whether the addition of transcranial direct current stimulation (TDCS) to speech fluency training results in improvements in speech fluency in adults with developmental stuttering.
Half of the participants will receive anodal TDCS on five consecutive days, the other half will receive a sham stimulation for the same amount of time.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Studies using TDCS have shown improvements in motor performance, and in expressive language skills in clinical and healthy populations.
The benefits of single sessions of TDCS are short-lived.
However, stimulation over multiple sessions can increase and prolong learning effects that can persist for several weeks after the end of the stimulation period.
We aim to target left hemisphere frontal regions involved in speech production with TDCS, and to pair this stimulation with speech fluency training.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Oxford, United Kingdom, OX1 3UD
- University of Oxford
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Native speaker of English.
- Right handed.
- Participant has moderate to severe Developmental Stuttering (Stammering)
Exclusion Criteria:
- Speech, language or communication disorder other than Developmental Stuttering.
- Sensory impairment (hearing loss or visual impairment)
- History of drug abuse.
- History of seizures
- History of a neurological or psychiatric illness.
- History of neurosurgical procedure.
- Currently taking certain prescription medications such as anti-depressants and anti-malarial medication (as these may lower the seizure threshold)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Anodal TDCS
Participants will receive anodal TDCS over the left inferior frontal cortex.
TDCS will be delivered at 1milliampere (mA) intensity for 20 minutes during speech fluency training (5 consecutive days).
|
20 minutes 1mA anodal stimulation to left inferior frontal cortex.
Cathode positioned on right supra-orbital ridge.
Speech tasks will be completed using fluency-enhancing techniques: metronome-timed speech and auditory choral speech.
|
|
Sham Comparator: Sham TDCS
Participants will receive sham TDCS over the left inferior frontal cortex.
Sham stimulation will involve 30 seconds stimulation at the beginning of the 20 minutes of speech fluency training (5 consecutive days).
|
Speech tasks will be completed using fluency-enhancing techniques: metronome-timed speech and auditory choral speech.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline proportion of stuttering in speech sample
Time Frame: 1 week post-treatment
|
Quantitative measurement of stuttering
|
1 week post-treatment
|
|
Change from baseline proportion of stuttering in speech sample
Time Frame: 6 weeks post-treatment
|
Quantitative measurement of stuttering
|
6 weeks post-treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline on the Stuttering Severity Instrument version 4 (SSI-4)
Time Frame: 1 week post-treatment
|
Standardised assessment of frequency and duration of stuttering and associated physical concomitants
|
1 week post-treatment
|
|
Change from baseline on the Stuttering Severity Instrument version 4 (SSI-4)
Time Frame: 6 weeks post-treatment
|
Standardised assessment of frequency and duration of stuttering and associated physical concomitants
|
6 weeks post-treatment
|
|
Change from baseline on Overall Assessment of Speaker's Experience of Stuttering (OASES)
Time Frame: 6 weeks post-treatment
|
Standardised assessment of the functional impact of stuttering on a person's life
|
6 weeks post-treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kate Watkins, PhD, University of Oxford
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Actual)
March 14, 2016
Study Completion (Actual)
March 14, 2016
Study Registration Dates
First Submitted
September 30, 2014
First Submitted That Met QC Criteria
November 6, 2014
First Posted (Estimate)
November 11, 2014
Study Record Updates
Last Update Posted (Estimate)
January 31, 2017
Last Update Submitted That Met QC Criteria
January 30, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MSD-IDREC-C2-2014-013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Speech Disorders
-
Riphah International UniversitySADA NGOCompletedChildren | Cochlear Implant | Speech Sound DisorderPakistan
-
Altec Inc.CompletedSpeech Disorders | Speech Perception | Rehabilitation of Speech and Language Disorders | Speech, Alaryngeal | Communication Aids for Disabled | Speech IntelligibilityUnited States
-
Prof. Dr. Cemil Tascıoglu Education and Research...CompletedHead and Neck Cancer | Speech Disorders | Speech Intelligibility | Speech | Speech DysfunctionTurkey
-
University of PittsburghDuquesne UniversityRecruiting
-
New York UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD); Syracuse... and other collaboratorsCompletedSpeech Sound DisorderUnited States
-
Pusan National University Yangsan HospitalNot yet recruitingPatients With Speech Disorders
-
University of Central FloridaNational Institute on Deafness and Other Communication Disorders (NIDCD); University...CompletedDown Syndrome | Speech Sound Disorder | Speech Disorders in Children | Speech Intelligibility | Speech and Language DisorderUnited States
-
Universidade Federal de Santa MariaCompleted
-
Boston University Charles River CampusThe University of Hong Kong; Tufts University; University of Arizona; University... and other collaboratorsCompletedPublic Speaking | Speech AnxietyUnited States, Australia, Netherlands, China, Germany
-
Yale UniversityCompleted
Clinical Trials on Anodal TDCS
-
Riphah International UniversityCompleted
-
University of WaterlooThe Hong Kong Polytechnic UniversityRecruitingMacular DegenerationHong Kong, Canada
-
Jingchu HuEnrolling by invitation
-
University of New MexicoNational Institute of General Medical Sciences (NIGMS)RecruitingAutism Spectrum Disorder | Autism or Autistic TraitsUnited States
-
University of WaterlooThe Hong Kong Polytechnic UniversityCompleted
-
New York UniversityRecruiting
-
Silvie CeresnakovaCompletedAnorexia NervosaCzechia
-
University College, LondonCompletedStroke | FatigueUnited Kingdom
-
Najat KhalifaUniversity of Nottingham; Medical Research CouncilCompletedImpulsive BehaviorUnited Kingdom
-
University of Nevada, Las VegasUnknownParkinson DiseaseUnited States